TrialBMC gastroenterology2018

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.

Renger G Tiessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.